Spark Biomedical is a medical device company focused on solutions to address addiction, withdrawal, and overall mental health. Spark's flagship product, the Sparrow therapy system, is a non-invasive wearable neurostimulator that alleviates nearly all withdrawal symptoms in as little as 30-60 minutes. The device sends electrical signals to the brain, driving endogenous endorphin production and calming the fight-or-flight instincts that create a near primal urge to use again. The Sparrow for adults is backed tier 1 clinical evidence and FDA cleared. The Sparrow Fledgling, for neonates, has undergone is first proof-of-concept trial with great success - and is now entering an NIH funded pivotal trial to obtain FDA approval.
